Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Blood Cancer Journal|April 24, 2020
A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cellsVanessa Rebecca Gasparini, Andrea Binatti, Alessandro Coppe, et al.
Cell Reports. Medicine|April 23, 2024
Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemiaShady Adnan Awad, Olli Dufva, Jay Klievink, et al.
European Journal of Haematology|December 31, 2013
Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular responsePerttu Koskenvesa, Anna Kreutzman, Peter Rohon, et al.
Oncotarget|December 13, 2017
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signalingHeikki Kuusanmäki, Olli Dufva, Elina Parri, et al.
Cancer Research|February 12, 2020
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CMLTom Hähnel, Christoph Baldow, Joëlle Guilhot, et al.
Blood Advances|March 23, 2019
Subclonal STAT3 mutations solidify clonal dominanceCassandra M Kerr, Michael J Clemente, Peter W Chomczynski, et al.
Biochemical and Biophysical Research Communications|June 18, 2017
Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34<sup>+</sup>CD38<sup>-</sup> stem and progenitor cells in chronic myeloid leukemiaMonika Dolinska, Alexandre Piccini, Wan Man Wong, et al.
Leukemia|November 10, 2020
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targetsShady Adnan-Awad, Daehong Kim, Helena Hohtari, et al.
Cancer Research Communications|July 24, 2023
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell CarcinomaMoon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, et al.
Blood|January 27, 2017
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CMLRebecca Warfvinge, Linda Geironson, Mikael N E Sommarin, et al.
Pageof 18